Literature DB >> 16397754

Meprobamate-tranquilizer or anxiolytic? A historical perspective.

Dilip Ramchandani1, Francisco López-Muñoz, Cecilio Alamo.   

Abstract

Meprobamate was the first successful anti-anxiety drug of the modern era. On the 50th anniversary of its introduction, the authors trace the development of its synthesis, marketing and runaway success to understand the scientific and socio-political factors that may have shaped its use in clinical psychiatry. The relationship of this drug to the earlier development of chlorpromazine is explored to clarify the imperatives of drug classification in modern psychiatry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397754     DOI: 10.1007/s11126-006-7960-z

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  20 in total

1.  Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.

Authors:  H D FABING
Journal:  Neurology       Date:  1955-05       Impact factor: 9.910

2.  The treatment of emotional disorders in obstetrics and gynecology with thioridazine.

Authors:  J C BROUGHER
Journal:  Q Rev Surg Obstet Gynecol       Date:  1960 Jan-Mar

3.  The pharmacological properties of alpha:beta-dihydroxy-gamma-(2-methylphenoxy)-propane (myanesin).

Authors:  F M Berger; W Bradley
Journal:  Br J Pharmacol Chemother       Date:  1946-12

4.  Milestones in clinical pharmacology. Psychopharmacology--depression and anxiety.

Authors:  G E Farrar
Journal:  Clin Ther       Date:  1991 Jul-Aug       Impact factor: 3.393

Review 5.  Sedatives and tranquilizers.

Authors:  R L Katz
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

6.  Meprobamate: a study of irrational drug use.

Authors:  D J Greenblatt; R I Shader
Journal:  Am J Psychiatry       Date:  1971-04       Impact factor: 18.112

Review 7.  The pharmacology of propanediol carbamates.

Authors:  B J Ludwig; J R Potterfield
Journal:  Adv Pharmacol Chemother       Date:  1971

8.  A critical review of the efficacy of meprobamate (miltown, equanil) in the treatment of anxiety.

Authors:  V G LATIES; B WEISS
Journal:  J Chronic Dis       Date:  1958-06

9.  Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.

Authors:  J C BORRUS
Journal:  J Am Med Assoc       Date:  1955-04-30

10.  A study of hypnotic drugs in patients with chronic diseases; comparative efficacy of placebo; methyprylon (noludar) meprobmate (miltown, equanil) pentobarbial; phenobarbital; secobarbital.

Authors:  L LASAGNA
Journal:  J Chronic Dis       Date:  1956-02
View more
  3 in total

Review 1.  Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors:  Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal:  Ochsner J       Date:  2017

Review 2.  Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish.

Authors:  David Kokel; Randall T Peterson
Journal:  Brief Funct Genomic Proteomic       Date:  2008-09-10

3.  Something old, something new: a successful case of meprobamate withdrawal.

Authors:  Alexander Owen James; Timothy R Nicholson; Robert Hill; Jennifer Bearn
Journal:  BMJ Case Rep       Date:  2016-02-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.